Parag P. Patwardhan - Concepedia

Author

Parag P. Patwardhan

Memorial Sloan Kettering Cancer Center

Also Known As

Parag P. Patwardhan, Parag Patwardhan

Publications

735

Citations

H-Index

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Columbia University Irving Medical Center Columbia University

About

Parag P. Patwardhan is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, cell signaling, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	223
2	Natural Sciences	2	2	223
3	Cell Biology	2	2	223
4	Cellular Physiology	2	2	223
5	Biochemistry	1	1	175

Parag P. Patwardhan

Publications

594

Citations

H-Index

Page 1

	Year	Citations
Myristoylation and Membrane Binding Regulate c-Src Stability and Kinase Activity Parag P. Patwardhan, Marilyn D. Resh Molecular and Cellular Biology Src BiologyMolecular BiologyCytoskeletonMembrane AssociationCellular Physiology	2010	175
Sustained Inhibition of Receptor Tyrosine Kinases and Macrophage Depletion by PLX3397 and Rapamycin as a Potential New Approach for the Treatment of MPNSTs Parag P. Patwardhan, Oliver Surriga, Michael J. Beckman, Clinical Cancer Research	2014	118
Significant blockade of multiple receptor tyrosine kinases by MGCD516 (Sitravatinib), a novel small molecule inhibitor, shows potent anti-tumor activity in preclinical models of sarcoma Parag P. Patwardhan, Kathryn S. Ivy, Elgilda Musi, Oncotarget	2015	111
MLN0128, an ATP-Competitive mTOR Kinase Inhibitor with Potent <i>In Vitro</i> and <i>In Vivo</i> Antitumor Activity, as Potential Therapy for Bone and Soft-Tissue Sarcoma Emily K. Slotkin, Parag P. Patwardhan, Shyamprasad Deraje Vasudeva, Molecular Cancer Therapeutics	2014	94
Individual Cas Phosphorylation Sites Are Dispensable for Processive Phosphorylation by Src and Anchorage-independent Cell Growth Parag P. Patwardhan, Yongquan Shen, Gary S. Goldberg, Journal of Biological Chemistry Molecular BiologyCell ProliferationCytoskeletonCell GrowthAnchorage-independent Cell Growth	2006	48
Targeted inhibition of glutaminase as a potential new approach for the treatment of <i>NF1</i> associated soft tissue malignancies Tahir Sheikh, Parag P. Patwardhan, Serge Cremers, Oncotarget	2017	29
Preclinical Evaluation of Nintedanib, a Triple Angiokinase Inhibitor, in Soft-tissue Sarcoma: Potential Therapeutic Implication for Synovial Sarcoma Parag P. Patwardhan, Elgilda Musi, Gary K. Schwartz Molecular Cancer Therapeutics	2018	19

Page 1